Prostate Cancer Videos
Latest Prostate Cancer News
Obesity is associated with greater risk of PCa among African-American men compared to non-Hispanic white men.
Enzalutamide improves health-related quality of life (HRQoL) in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).
Increased risks of mortality restricted to aspirin use after the diagnosis of prostate cancer.
Increased likelihood of prostate cancer seen with fourth repeat biopsy, men.
The Prostate Health Index improves detection of clinically significant prostate cancer.
Median time to death was shortest in men with metastatic disease at diagnosis.
High LDL cholesterol and high blood glucose, however, did increase the risk of PSA relapse.
Research raises concern about the simultaneous use of chemotherapy and fish oil.
Physical side effects seen over first 12 months of androgen deprivation therapy (ADT) persisted or worsened over 3 years of follow-up.
Researchers conclude that intermediate-risk PCa be stratified into favorable or unfavorable risk subgroups.
In a small study of mCRPC patients, the median time on therapy increased by nearly 100 days and PSA declined in some subjects.
Imaging was associated with a lower risk of positive surgical margins in men with cT1 prostate tumors, but not in other subgroups.
Within 10 years of surgery, men younger than 60 years are more likely to die from prostate cancer than from other causes.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)